139 related articles for article (PubMed ID: 30018810)
1. Potential new biomarkers for squamous carcinoma of the uterine cervix.
van Dam PA; Rolfo C; Ruiz R; Pauwels P; Van Berckelaer C; Trinh XB; Ferri Gandia J; Bogers JP; Van Laere S
ESMO Open; 2018; 3(4):e000352. PubMed ID: 30018810
[TBL] [Abstract][Full Text] [Related]
2. In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.
van Dam PA; van Dam PJ; Rolfo C; Giallombardo M; van Berckelaer C; Trinh XB; Altintas S; Huizing M; Papadimitriou K; Tjalma WA; van Laere S
Oncotarget; 2016 Jan; 7(3):2780-95. PubMed ID: 26701206
[TBL] [Abstract][Full Text] [Related]
3. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women.
Hansel A; Steinbach D; Greinke C; Schmitz M; Eiselt J; Scheungraber C; Gajda M; Hoyer H; Runnebaum IB; Dürst M
PLoS One; 2014; 9(3):e91905. PubMed ID: 24647315
[TBL] [Abstract][Full Text] [Related]
4. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray.
Wong YF; Cheung TH; Tsao GS; Lo KW; Yim SF; Wang VW; Heung MM; Chan SC; Chan LK; Ho TW; Wong KW; Li C; Guo Y; Chung TK; Smith DI
Int J Cancer; 2006 May; 118(10):2461-9. PubMed ID: 16353136
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
7. Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program.
Hortlund M; Mühr LSA; Lagheden C; Hjerpe A; Dillner J
Int J Cancer; 2021 Dec; 149(12):2083-2090. PubMed ID: 34418082
[TBL] [Abstract][Full Text] [Related]
8. Variation in apoptotic gene expression in cervical cancer through oligonucleotide microarray profiling.
Zhu MY; Chen F; Niyazi M; Sui S; Gao DM
J Low Genit Tract Dis; 2015 Jan; 19(1):46-54. PubMed ID: 24914885
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer.
Koch M; Wiese M
J Cancer Res Clin Oncol; 2013 Feb; 139(2):259-67. PubMed ID: 23052694
[TBL] [Abstract][Full Text] [Related]
10. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
11. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
[TBL] [Abstract][Full Text] [Related]
12. Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer.
Zhu XL; Wen SY; Ai ZH; Wang J; Xu YL; Teng YC
Mol Med Rep; 2015 Jul; 12(1):55-62. PubMed ID: 25695263
[TBL] [Abstract][Full Text] [Related]
13. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
14. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
15. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
16. TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.
Manawapat-Klopfer A; Thomsen LT; Martus P; Munk C; Russ R; Gmuender H; Frederiksen K; Haedicke-Jarboui J; Stubenrauch F; Kjaer SK; Iftner T
Am J Cancer Res; 2016; 6(7):1524-36. PubMed ID: 27508094
[TBL] [Abstract][Full Text] [Related]
17. Gene identification by cDNA arrays in HPV-positive cervical cancer.
Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M
Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320
[TBL] [Abstract][Full Text] [Related]
18. HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.
Andersen B; Njor SH; Jensen AMS; Johansen T; Jeppesen U; Svanholm H
Int J Gynecol Cancer; 2020 Nov; 30(11):1678-1683. PubMed ID: 33037107
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
